PAINCEPTOR
DEAD

Serial Number

78731402

Owner

PainCeptor Pharma Corporation

Attorney

Terrence J. McAllister

Filing Date

Oct 12, 2005

Add to watchlist:

No watchlists yet
View on USPTO

PAINCEPTOR Trademark

Serial Number: 78731402

PAINCEPTOR is a trademark filed by PainCeptor Pharma Corporation on October 12, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PainCeptor Pharma Corporation

Suite 100
St-Laurent , Quebec H4S 2C1 , CA

Entity Type: 03

Trademark Details

Filing Date

October 12, 2005

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Schizophrenia, learning disorders, Bipolar Disorder, Depression, Alzheimer's Disease, Epilepsy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Stroke, Addiction, Cerebral Ischemia, Neuropathy, Retinal Pigment Degeneneration, Glaucoma, Cardiac Arrhythmia, Shingles, Huntington's Chorea, Parkinson's Disease and anxiety disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases of the musculoskeletal and connective tissue system, Respiratory system, Circulatory system, Gastrointestinal system, Genitourinary system and Nervous system; Pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal and connective tissue system, namely, Arthritis, Psoriasis, Myocitis, Dermatitis, bone cancer and eczema; Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system, namely, Asthma, Bronchitis, Sinusitis, Pharyngitis, Laryngitis, Tracheitis, rhinitis, Cystic fibrosis, Respiratory Infection, Acute respiratory Distress syndrome and emphysema; Pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system, namely, Vasculitis, Haematuria syndrome, Artherosclerosis, Arteritis, Phlebitis, Carditis, Coronary Heart Disease, Ischemic Heart Disease, Angina and Acute Myocardial Infarction; Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, namely, Irritable Bowel Syndrome, Ulcerative colitis, Crohn's Disease, Diverticulitis, Viral and Bacterial Infection, Peptic ulcer, Chronic hepatitis, Gingivitis, Periodentitis, Stomatitis, Gastritis, Gastrointestinal reflux disease and GI cancers; Pharmaceutical preparations for the treatment of the genitourinary diseases and disorders, namely, Cystitis, Polycystic kidney disease, Nephritic syndrome, Urinary Tract infection, Kidney Stones, Cystinosis, Prostatitis, Salpingitis, Endometriosis and GU cancers; Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, namely, Neuralgia, Neuropathy, Chronic cephalic pain, headache, migraine, psychogenic pain and spinal cord injury

Pharmaceutical research and development, product evaluation and drug development

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 10, 2011 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 10, 2011 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 15, 2010 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 15, 2010 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 15, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 30, 2010 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 30, 2009 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 17, 2009 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 17, 2009 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 15, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 12, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 12, 2008 GNSL
SUSPENSION LETTER WRITTEN
Dec 12, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 10, 2008 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 17, 2008 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 17, 2008 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 17, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 28, 2008 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 26, 2007 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 26, 2007 GNSL
SUSPENSION LETTER WRITTEN
Nov 26, 2007 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2007 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2007 TROA
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 10, 2007 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 10, 2007 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 10, 2007 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 26, 2007 RCCK
ASSIGNED TO LIE
May 26, 2007 ALIE
LETTER OF SUSPENSION E-MAILED
Nov 21, 2006 GNSL
SUSPENSION LETTER WRITTEN
Nov 21, 2006 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2006 TROA
NON-FINAL ACTION E-MAILED
Apr 17, 2006 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2006 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2006 DOCK
NEW APPLICATION ENTERED
Oct 18, 2005 NWAP